Microline Surgical, a subsidiary of HOYA Corporation, today announced that it has acquired the rights to certain laparoscopic instrumentation assets from RETRACTION Limited.

The acquisition includes REVEEL branded products, which are used by surgeons for liver retraction in laparoscopic surgeries.

The REVEEL devices are engineered to gently retract the liver and provide an unobstructed view of the surgical site during a procedure. REVEEL’s patented surface also protects the liver from sliding during procedures.

The REVEEL products have been cleared and are available for sale in many countries, including the United States, the United Kingdom, and the EU.

“We are pleased to announce the signing of this agreement, as the addition of REVEEL to the Microline portfolio enhances Microline’s mission to enable customers to reduce surgical costs and complications, and to improve surgical outcomes,” said Timothy Gehlmann, President and Chief Executive Officer of Microline.

“We are thrilled to transfer the rights to our REVEEL Endoscopic Retractor to Microline. Microline is a strong partner, and this transition will enable a greater number of patients and medical practitioners to benefit from our patented technology,” said Stuart Moran, Chief Executive Officer of RETRACTION Limited.

Source: Company Press Release